March 18, 2021

Okategoriserade

FluoGuide appoints new Certified Adviser

Copenhagen, Denmark, 18 March 2021 – FluoGuide A/S (“FluoGuide” or the “Company) appoints Svensk Kapitalmarknadsgransking AB as its new Certified Adviser.... [Read more]

March 9, 2021

Okategoriserade

FluoGuide acquires rights to photothermal therapy using FG001

Copenhagen, Denmark, 9 March 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the Company has acquired... [Read more]

February 17, 2021

Okategoriserade

FluoGuide gets green light to proceed to fourth dose level with FG001 in the ongoing clinical phase I/II trial in patients with high grade glioma

Copenhagen, Denmark, 17 February 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the dose escalation committee... [Read more]

February 9, 2021

Okategoriserade

Minutes from the Annual General Meeting in FluoGuide A/S

Copenhagen, Denmark, 9 February 2021 – FluoGuide A/S, CVR no. 39 29 64 38 (“FluoGuide” or the “Company”) held its Annual... [Read more]

February 5, 2021

Okategoriserade

FluoGuide announces approval for listing on Nasdaq First North Growth Market Sweden on the 24 February 2021

Copenhagen, Denmark, 5 February 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) has today received approval for admission to trading on... [Read more]